T7 Expression Vectors for Toxic Protein Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current inducible T7 expression systems face challenges in maintaining stability and controlling expression levels, particularly for toxic proteins, due to high basal production of target proteins, which can be toxic to host cells, leading to unstable expression strains.

Innovation Solution

Development of improved cloning and expression vectors, including the T7 Promoter Control Region and Translation Initiation Efficiency Region, that utilize asymmetric ligation for directional cloning and co-expression, along with engineered cells containing these vectors and inducible T7 RNA polymerase, to minimize basal expression and enhance control over target protein production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If T7 RNA polymerase is highly active and processive to produce mRNA efficiently, then target protein production is high, but basal expression produces enough toxic target protein to prevent establishment of stable inducible expression strains

Engineering Contradiction:
Improvetarget protein production efficiencyVSAvoidstability of inducible expression strain
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The promoter region is segmented into multiple functional elements: T7 promoter sequence for high-level transcription, lac operator sequences for regulation, and spacing elements. This segmentation allows independent optimization of each element's function - the T7 promoter provides high productivity while the lac operators provide stability through regulated control.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The lac operator sequences act as intermediaries between the T7 promoter and the target gene. These operators bind lac repressor to prevent basal transcription by T7 RNA polymerase, while allowing induced transcription when lactose or IPTG is present. This intermediary mechanism resolves the contradiction by decoupling the high productivity capability from toxic basal expression.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If T7 RNA polymerase selectively initiates transcription at T7 promoter to achieve high efficiency, then resource command is efficient, but toxic proteins are produced at basal levels that destabilize expression strains

Engineering Contradiction:
Improvetranscription efficiencyVSAvoidtoxicity of basal protein expression
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The lac operator sequences are placed strategically within the promoter region to preemptively block T7 RNA polymerase binding and transcription initiation at basal levels. This preliminary anti-action prevents the harmful effect of toxic protein production before it occurs, while allowing high-level transcription to proceed when the lac repressor is removed by induction.

Inventive Principle:
Principle #9Preliminary anti-action

3Object-affected harmful factors

If cloning site is oriented opposite to tet promoter to reduce basal transcription, then toxic protein production is reduced, but control over expression is limited

Engineering Contradiction:
Improvebasal transcription levelVSAvoidexpression control flexibility
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The promoter region incorporates multiple functional elements that serve different purposes: T7 promoter for high-level transcription, lac operators for inducible control, and spacing elements for optimization. This multi-functional design provides both reduced basal expression and flexible inducible control, resolving the contradiction between reducing harmful basal transcription and maintaining expression versatility.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11618899B2Cloning and expression vectors and systems
Publication Date: 2023.04.04 BROOKHAVEN SCIENCE ASSOCIATES LLC
  • US11618899B2 patent drawing
  • US11618899B2 patent drawing
  • US11618899B2 patent drawing

AI summary

Vectors for cloning, maintaining and expressing a wide range of coding sequences in inducible T7 expression systems in Escherichia coli expression hosts are disclosed herein. Target genes that can be stably maintained and expressed include those that specify proteins that are highly toxic to the host cell. Different configurations of vectors and expression hosts provide different rates of transcription and translation of target genes and therefore different rates of accumulation of target proteins. Methods for cloning by asymmetric ligation and co-expression of more than one target protein in a single vector are also disclosed, as are variants of BL21(DE3) having lower basal transcription by T7 RNA polymerase.